Mackenzie Financial
TARS icon

Mackenzie Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

Mackenzie Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
+191,428
New +$12.2M 0.01% 572
2026
Q1 		– Sell
-2,454
Closed -$202K – 1742
2025
Q4 		$202K Buy
+2,454
New +$183K ﹤0.01% 1543

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mackenzie Financial's TARS Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 191,428 shares worth $12M. The stake represents 0.01% of the portfolio and ranks #572 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in TARS as recently as Q4 2025.

Mackenzie Financial first reported a position in TARS in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Mackenzie Financial held 191,428 shares of Tarsus Pharmaceuticals worth $12M as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Mackenzie Financial position in Q2 2026.
  • Tarsus Pharmaceuticals made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #572 holding.
  • Mackenzie Financial first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.